Clinical efficacy comparison of avapritinib with other tyrosine kinase inhibitors in gastrointestinal stromal tumors with PDGFRA D842V mutation: a retrospective analysis of clinical trial and real-world data.
Margaret von MehrenMichael C HeinrichHongliang ShiSergio IannazzoRaymond MankoskiSaša DimitrijevićGerard HoehnSilvia ChiroliSuzanne GeorgePublished in: BMC cancer (2021)
The NAVIGATOR trial was registered at ClinicalTrials.gov as per July 2015, Identifier: NCT02508532 .